Skip to main content
Top
Published in: Cancer Causes & Control 9/2009

01-11-2009 | Original paper

A community effort to reduce the black/white breast cancer mortality disparity in Chicago

Authors: David Ansell, Paula Grabler, Steven Whitman, Carol Ferrans, Jacqueline Burgess-Bishop, Linda Rae Murray, Ruta Rao, Elizabeth Marcus

Published in: Cancer Causes & Control | Issue 9/2009

Login to get access

Abstract

Background

The Metropolitan Chicago Breast Cancer Taskforce was formed to address a growing black/white breast cancer mortality disparity in Chicago. The Taskforce explored three hypotheses: black women in Chicago receive fewer mammograms, black women receive mammograms of inferior quality, and black women have inadequate access to quality of treatment for breast cancer.

Methods

A total of 102 individuals from 74 Chicago area organizations participated in the Task Force participating in three work groups from January to September 2007. The work groups held focus groups of providers, organized town hall meetings in four Chicago communities, gathered black/white breast cancer mortality data for Chicago, the United States, and New York City, and conducted a mammography capacity and quality survey of mammography facilities.

Results

Chicago’s black and white breast cancer mortality rates were the same in 1980. By the late 1990s, a substantial disparity was present, and by 2005, the black breast cancer mortality rate was 116% higher than the white rate. In 2007, 206,000 screening mammograms were performed for women living in Chicago, far short of the 588,000 women in the 40–69 age range in Chicago. Facilities that served predominately minority women were less likely to be academic or private institutions (p < .03), less likely to have digital mammography (p < .003), and less likely to have dedicated breast imaging specialists reading the films (p < .003). Black women and providers serving them reported significant difficulties in accessing needed care for breast cancer screening and treatment.

Conclusion

There are significant access barriers to high quality mammography and treatment services that could be contributing to the mortality differences in Chicago. A metropolitan wide taskforce has been established to address the disparity.
Literature
1.
go back to reference Hirschman J, Whitman S, Ansell D, Grabler P, Allgood K (2006) Breast cancer in Chicago: eliminating disparities and improving mammography quality. Sinai Urban Health Institute, Chicago Hirschman J, Whitman S, Ansell D, Grabler P, Allgood K (2006) Breast cancer in Chicago: eliminating disparities and improving mammography quality. Sinai Urban Health Institute, Chicago
3.
go back to reference Metropolitan Chicago Breast Cancer Taskforce (2007) Improving quality and reducing disparities in metropolitan Chicago. Chicago, IL Metropolitan Chicago Breast Cancer Taskforce (2007) Improving quality and reducing disparities in metropolitan Chicago. Chicago, IL
6.
go back to reference Government Accounting Office (GAO) (2002) Mammography-capacity generally exists to deliver services. Washington, DC, Apr. report no. GAO-02-532 Government Accounting Office (GAO) (2002) Mammography-capacity generally exists to deliver services. Washington, DC, Apr. report no. GAO-02-532
8.
go back to reference American College of Radiology (ACR) (2003) Breast imaging reporting and data systems (BI-RADS), 4th edn. American College of Radiology, Reston, VA American College of Radiology (ACR) (2003) Breast imaging reporting and data systems (BI-RADS), 4th edn. American College of Radiology, Reston, VA
13.
go back to reference Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J et al (2006) Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144:541–553PubMed Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J et al (2006) Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144:541–553PubMed
16.
go back to reference Miglioretti DL, Smith-Bindman R, Abraham L, Brenner RJ, Carney PA et al (2007) Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst 99:1854–1863. doi:10.1093/jnci/djm238 CrossRefPubMed Miglioretti DL, Smith-Bindman R, Abraham L, Brenner RJ, Carney PA et al (2007) Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst 99:1854–1863. doi:10.​1093/​jnci/​djm238 CrossRefPubMed
17.
go back to reference Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum J, Acharyya S, Conant E, Fajardo L, Bassett D’OrsiC et al (2007) Diagnostic performance of digital versus film mammography for breast-cancer screening. NEJM 353:1773–1783. doi:10.1056/NEJMoa052911 CrossRef Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum J, Acharyya S, Conant E, Fajardo L, Bassett D’OrsiC et al (2007) Diagnostic performance of digital versus film mammography for breast-cancer screening. NEJM 353:1773–1783. doi:10.​1056/​NEJMoa052911 CrossRef
24.
go back to reference Ferrante JM, Chen PH, The KimS (2008) Effect of patient navigation on time to diagnosis, anxiety, satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health 85(1):114–124CrossRefPubMed Ferrante JM, Chen PH, The KimS (2008) Effect of patient navigation on time to diagnosis, anxiety, satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health 85(1):114–124CrossRefPubMed
25.
go back to reference Battaglia TA, Roloff K, Posner MA, Freund KM (2007) Improving follow-up to abnormal breast cancer screening in an urban population: a patient navigation intervention. Cancer 109(2 Suppl):359–367CrossRefPubMed Battaglia TA, Roloff K, Posner MA, Freund KM (2007) Improving follow-up to abnormal breast cancer screening in an urban population: a patient navigation intervention. Cancer 109(2 Suppl):359–367CrossRefPubMed
Metadata
Title
A community effort to reduce the black/white breast cancer mortality disparity in Chicago
Authors
David Ansell
Paula Grabler
Steven Whitman
Carol Ferrans
Jacqueline Burgess-Bishop
Linda Rae Murray
Ruta Rao
Elizabeth Marcus
Publication date
01-11-2009
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 9/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9419-7

Other articles of this Issue 9/2009

Cancer Causes & Control 9/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine